scientists of Tomsk Polytechnic University are conducting clinical trials of medicines in Mexico, because they can not find investors in Russia, said Professor of the research school of chemical and biomedical technologies of the University A. Pestryakov. According to him, the Mexican population through such cooperation receives quality medical care, and the government - prestige. According to the Director of the research school M. Yusupov, within the framework of the "Pharma 2020" program in Russia only 1% of drugs are transferred from preclinical trials to clinical trials. He also noted that clinical trials take about 70% of the total cost of creating a drug.

GMPnews.ru, 27.04.2018, " in RUSSIA from PRECLINICAL TRIALS

in CLINICAL TRIALS

ONLY 1% of drugs "